title: The role of the FDA in the national cancer program: friend or foe?
authors.forename: Philip S
authors.initials: PS
authors.lastname: Schein
authors.forename: Barbara
authors.initials: B
authors.lastname: Scheffler
authors.forename: Stephen
authors.initials: S
authors.lastname: Carter
mesh_terms: D000970:Antineoplastic Agents; D017277:Drug Approval; D017598:Efficiency, Organizational; D005380:Financing, Government; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009937:Organizational Objectives; D017149:Private Sector; D011640:Public Policy; D017150:Public Sector; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents